Rion Co., Ltd. (JP:6823)
:6823
Want to see JP:6823 full AI Analyst Report?
6823 Stock Chart & Stats
¥2691.00
-¥68.00(-2.64%)
At close: 4:00 PM EST
¥2691.00
-¥68.00(-2.64%)
Day’s Range― - ―
52-Week Range¥2,294.00 - ¥3,310.00
Previous CloseN/A
Volume32.10K
Average Volume (3M)26.46K
Market Cap
¥39.40B
Enterprise Value¥34.14B
Total Cash (Recent Filing)¥6.16B
Total Debt (Recent Filing)¥1.73B
Price to Earnings (P/E)10.2
Beta1.11
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.93%
Share Statistics
EPS (TTM)88.99
Shares Outstanding12,347,700
10 Day Avg. Volume21,140
30 Day Avg. Volume26,463
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)0.96
Price to Sales (P/S)1.09
P/FCF Ratio14.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)304.1
Revenue Forecast (FY)¥31.20B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained ~61% top-line growth indicates durable demand for Rion’s measurement and medical devices across industrial, environmental, and healthcare end markets. Over 2–6 months this supports scaling advantages, stronger distributor relationships, and room to invest in product development and service expansion.
Margin SustainabilityA ~50% gross margin provides a meaningful profitability buffer against input cost swings, while stable ~10% net margin shows consistent operating discipline. This margin profile supports reinvestment for product improvement and service capabilities, underpinning durable earnings power over the medium term.
Balance Sheet & Cash GenerationVery low leverage and improving free cash flow give Rion financial flexibility to fund R&D, capital equipment, or targeted M&A without stressing liquidity. Strong operating cash versus net income reduces refinancing risk and supports steady investment in durable product and service capabilities.
Bears Say
Moderate Net MarginA ~10% net margin, while stable, limits the absolute cash retained for reinvestment relative to faster-growing peers. Over 2–6 months this can constrain the pace of expanding recurring service offerings or larger strategic initiatives, making growth more dependent on revenue expansion than margin expansion.
Modest Return On EquityROE near 9% signals only modest efficiency in converting equity into returns. Structurally, this may limit shareholder value creation and reduce internal funding available for aggressive expansion or higher-return projects, slowing cumulative growth over the medium term.
Revenue Concentration In Hardware SalesDependence on product sales (measurement instruments and medical devices) means revenue is more cyclical and capex-sensitive than subscription-like models. Limited recurring revenue reduces predictability and customer stickiness, increasing vulnerability to demand swings and elongating payback on sales investments.
Rion Co., Ltd. News
6823 FAQ
What was Rion Co., Ltd.’s price range in the past 12 months?
Rion Co., Ltd. lowest stock price was ¥2294.00 and its highest was ¥3310.00 in the past 12 months.
What is Rion Co., Ltd.’s market cap?
Rion Co., Ltd.’s market cap is ¥39.40B.
When is Rion Co., Ltd.’s upcoming earnings report date?
Rion Co., Ltd.’s upcoming earnings report date is Aug 05, 2026 which is in 98 days.
How were Rion Co., Ltd.’s earnings last quarter?
Rion Co., Ltd. released its earnings results on Apr 28, 2026. The company reported ¥88.99 earnings per share for the quarter, beating the consensus estimate of N/A by ¥88.99.
Is Rion Co., Ltd. overvalued?
According to Wall Street analysts Rion Co., Ltd.’s price is currently Overvalued.
Does Rion Co., Ltd. pay dividends?
Rion Co., Ltd. pays a Semiannually dividend of ¥35 which represents an annual dividend yield of 2.93%. See more information on Rion Co., Ltd. dividends here
What is Rion Co., Ltd.’s EPS estimate?
Rion Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rion Co., Ltd. have?
Rion Co., Ltd. has 12,347,700 shares outstanding.
What happened to Rion Co., Ltd.’s price movement after its last earnings report?
Rion Co., Ltd. reported an EPS of ¥88.99 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.772%.
Which hedge fund is a major shareholder of Rion Co., Ltd.?
Currently, no hedge funds are holding shares in JP:6823
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rion Co., Ltd.
Rion Co., Ltd. manufactures, sells, and maintains hearing instruments, medical equipment, sound and vibration measuring instruments, particle counters, and related parts and equipment in Japan. The company's audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom made, and analog body aid instruments, as well as waterproof hearing instruments; and medical equipment comprising audiometers and OAE screeners. Its sound and vibration measuring instruments include sound level meters, vibration meters, seismometers, frequency analyzers, microphones and accelerometers, recorders, and other products. The company's particle counters comprise air and liquid- borne particle counters, and viable particle counters. Its products are primarily used in the applications of environment-related administration, electronics, semiconductors, pharmaceutical, and food manufacturing industries. The company was formerly known as Kobayashi-Riken Seisakusho Ltd. and changed its name to Rion Co., Ltd. in 1960. Rion Co., Ltd. was incorporated in 1944 and is headquartered in Kokubunji, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---